BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33964611)

  • 21. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
    Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
    J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
    Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
    BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
    Krishnan V; Sauthier P; Provencher D; Rahimi K
    Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms Predict Cancer-Specific and Overall Survival of Patients With Primary Limb Leiomyosarcoma.
    Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
    J Orthop Res; 2019 Jul; 37(7):1649-1657. PubMed ID: 30977539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival.
    Baudo A; Piccinelli ML; Incesu RB; Morra S; Scheipner L; Barletta F; Tappero S; Garcia CC; Assad A; Tian Z; Acquati P; de Cobelli O; Longo N; Briganti A; Terrone C; Chun FKH; Tilki D; Ahyai S; Saad F; Shariat SF; Carmignani L; Karakiewicz PI
    Surg Oncol; 2024 Jun; 54():102074. PubMed ID: 38615387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
    Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
    Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
    Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
    Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
    Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
    Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of survival and recurrence in primary leiomyosarcoma.
    Gladdy RA; Qin LX; Moraco N; Agaram NP; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jun; 20(6):1851-7. PubMed ID: 23354568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional survival of extremity soft-tissue sarcoma: results beyond the staging system.
    Parsons HM; Habermann EB; Tuttle TM; Al-Refaie WB
    Cancer; 2011 Mar; 117(5):1055-60. PubMed ID: 20960489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.
    Zhan X; Guo J; Chen L; Deng W; Liu X; Zhu K; Liu W; Fu B
    Cancer Med; 2021 Oct; 10(19):6868-6880. PubMed ID: 34423585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
    Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
    Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.
    Gordon RW; Tirumani SH; Kurra V; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH
    Skeletal Radiol; 2014 May; 43(5):615-22. PubMed ID: 24496586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern.
    Carneiro A; Bendahl PO; Engellau J; Domanski HA; Fletcher CD; Rissler P; Rydholm A; Nilbert M
    Cancer; 2011 Mar; 117(6):1279-87. PubMed ID: 21381015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database.
    Johnson AC; Ethun CG; Liu Y; Poultsides G; Howard JH; Bedi M; Charlson J; Tseng J; Roggin KK; Votanopoulos K; Cullinan D; Fields RC; Maithel SK; Cardona K;
    J Surg Oncol; 2018 Dec; 118(7):1135-1141. PubMed ID: 30261111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.